Hindustan Foods Ltd Q4 FY2026 Concall Summary

Key Takeaways

• Record profitability, cash flow lags: FY26 delivered record EBITDA, PBT and PAT, but cash flows were dented by GST duty inversion and a deliberate inventory build to protect customers from geopolitical supply shocks.
• Footwear margin squeeze is the near-term pain: A 50–60% spike in imported polymer prices hit the footwear division in Q4 and continues into Q1, and because these are shared-manufacturing contracts, the pass-through is a negotiation, not automatic.
• A ₹500 cr asset ramp-up is the FY27 engine: Assets either in ramp-up, CWIP or commissioned late in FY26 (Panipat, Aurangabad, cone facility) are set to drive a significant volume jump, with Panipat alone adding 50% to ice cream capacity.
• Revenue recognition reset is coming, but delayed: The shift from gross to net revenue accounting for the foods segment, originally slated for H1 FY27, has been pushed to Q2–Q3 as customer discussions took a back seat to geopolitical firefighting.
• What to watch next quarter: Whether footwear raw material costs are successfully passed on, the pace of ramp-up at Panipat and other new assets, and how many food customers have agreed to the net revenue model transition.

The Footwear Margin Squeeze

• Raw material shock: Polymer prices for soles, largely imported from the Far East, rose nearly 50–60% alongside substantially higher freight rates, hitting a division that reached ₹500 cr turnover and turned PAT-positive in Q2.
• Shared-manufacturing economics bite: Unlike dedicated contracts where raw material costs are directly passed through, footwear operates on a shared-manufacturing model where pricing changes are negotiated, not instantaneous, so the division absorbed the impact in Q4 and continues to do so in Q1.
• Pass-through confidence, but no timeline guarantee: Management is confident of working with customers to pass on cost increases within the next month or so, but declined to give a footwear profitability target for FY27, citing too much variability in raw material prices and ongoing discussions.
• PAT guidance intact despite the squeeze: Headwinds in footwear are expected to be compensated by growth in other categories, and management reiterated FY27 PAT guidance of ₹200–220 cr, though it will revisit if uncertainty persists.
• ROCE expectation under pressure: Shared manufacturing carries a higher ROCE expectation due to higher risk, and management acknowledged the shoe business is currently not meeting that higher threshold.

Kothari: "Profitability target is something that I would much rather not talk about, especially for this division right now because there's just too much variability in terms of the raw material prices and our discussions with the customers are still ongoing."

The ₹500 cr Asset Ramp-Up

• What is in the base: Approximately ₹508 cr of assets are either in ramp-up stage, capital work in progress, or started production but have not contributed a full year of earnings. Panipat was recorded as CWIP in FY26 and earnings begin in FY27; Aurangabad Personal Care and the cone manufacturing facility contributed only a couple of months or none at all.
• Panipat is the single biggest lever: The newly commissioned ice cream facility, built in under 10 months, adds 50% to the company's ice cream production capacity and is expected to drive a significant jump in total production volume between FY26 and FY27.
• Beverages scaling to a milestone: With new bottle capacity in Aurangabad and South India commissioning during FY27, management expects to become the single largest independent bottler of beverages in India by end of FY27, manufacturing for multiple brands with no brand affiliation.
• Ice cream backward integration complete: The acquisition of a cone manufacturing facility and commissioning of a stick manufacturing facility capture a bigger share of the value chain and enable better service to existing and new customers.
• New contracts already flowing: ₹150 cr of new contracts have been signed since April, spanning the last 45 days, providing near-term visibility into the ramp-up.

Kothari: "We will probably, at the end of FY27, become the single largest independent bottler of beverages in the country. And by independent, I mean we do not have an affiliation to any brand. We are manufacturing for multiple brands, and we will be the single largest independent bottler in the country."

Revenue Recognition Reset

• The GST inversion problem: Most food categories shifted to a 5% GST rate while packaging and some raw materials carry higher rates, creating an inverted duty structure that traps working capital. The foods segment is the most affected.
• The fix, delayed: The planned transition from gross revenue recognition to a net revenue (conversion cost) model has been pushed from a Q1–Q2 timeline to Q2–Q3 FY27. Discussions with customers went to the back burner as both parties focused on stocking inventory amid geopolitical disruption.
• Accounting change, not economic change: The transition will reduce reported revenue but will not affect absolute EBITDA or PAT. Margins will mechanically improve because the denominator shrinks, and management noted that if all customers agree, PAT margin could reach 10% purely as an accounting change.
• Quantification still pending: Management could not quantify how many customers have agreed to the new model and will provide an update in the next investor call.

Kothari: "This particular discussion of changing the way of doing business has gone to a little bit of a back burner, which is why we've shifted the goalpost in terms of when we will be making this transition."

Working Capital & Cash Flow

• Cash flows less than satisfactory: Despite meeting profit guidance, cash flows were impacted by two factors: the GST inverted duty structure effective September 2025, and a proactive inventory buildup to ensure no production loss for customers amid geopolitical supply chain uncertainty.
• Capex not constrained: Management has secured working capital credit across product lines, so the elevated working capital deployment is not limiting the company's ability to invest.
• GST duty inversion as a structural drag: The mismatch between input and output GST rates continues to trap cash until the net revenue model transition is completed, now expected by Q3 FY27.

Divisional Restructuring & Disclosure

• Five divisions, one mandate: The company has been restructured into five divisions with new leadership, each given a clear mandate to grow EBITDA at 20% and deliver 20% ROE. The company as a whole should grow at 20%, per management.
• Segment disclosure expanding, but profitability stays guarded: Management has started disclosing gross block invested per segment and capital allocation by category. It committed to providing segment-wise EBITDA numbers towards the end of FY27, but declined to give BU-wise profitability now, arguing the numbers would be a proxy for customer performance.
• ROCE threshold disclosed: Every project or acquisition is evaluated against an internal threshold of 18% IRR over a longish period, a disclosure management made to explain capital allocation discipline.
• Revenue guidance withheld: Management is avoiding sales guidance due to two opposing forces: the shift to a conversion cost model (downward pressure on reported sales) and inflation (upward pressure), neither of which affects company performance.

Kothari: "The mandate given to the management is very clear that we should be able to grow at 20% in each of our BUs. And as a result, the company as a whole should definitely grow at 20%."

New Initiatives & Customer Expansion

• Healthcare gaining traction: The healthcare facility, which holds U.S. FDA and Russian FDA approvals, signed 3–4 new customers. Management is pursuing exports with a contrarian approach despite global supply chain uncertainty, including discussions with large U.S. modern trade players, with tangible data expected in the next couple of quarters.
• Greek yogurt entry: HFL is entering the Greek yogurt segment as part of a strategy to expand into higher-value, wellness-oriented dairy categories.
• Wellness and Ayurveda build-out: A dedicated Ayurvedic wellness manufacturing facility is being established at Baddi, alongside modernization of the existing facility.
• Home and Personal Care deepening: The Aurangabad Personal Care facility has been successfully integrated, strengthening the ability to cater to D2C and premium product categories requiring small production batches.
• Strongest engagement in core categories: Management cited the strongest customer traction in home care, beverages and ice creams, with active engagement across all ice cream customers and new brand launches across categories.

Guidance & Commitments

Key Metrics